How to Effectively Use Patent Counsel to Navigate the USPTO’s Duty of Candor Guidance Regarding FDA Submissions

Published date13 December 2022
AuthorAydin H. Harston and Gary Prato
Subject MatterHealth Care
Law FirmRothwell Figg

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT